MedTrace Logo

Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications

NCT02094118 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2021-04-06

Study results available
· View outcomes & findings →

Summary

This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to standard-of-care Leukocyte-Reduced Red Blood Cells in a cardiac surgical population.

Conditions

  • Blood Transfusion Complications

Interventions

BIOLOGICAL

Point-of-care washed red blood cell transfusion.

BIOLOGICAL

Standard of care red blood cell transfusion.

Sponsors & Collaborators

Principal Investigators

  • Daryl Kor, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-05-30
Completion
2019-05-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094118 on ClinicalTrials.gov